- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04078087
The Effect of Body Mass Index In Relation To Menstrual Cycle Phase on Propofol Injection Pain
There are suggestions from experimental pain studies that pain perception in patients with severe obesity differs compared with individuals with lower BMI values, with a tendency for patients with severe obesity to be hypoalgesic - that is, to have reduced numerical pain scores to a variety of painful stimuli. That finding could be related to: associated reduced cognitive function (complex attention, verbal and visual memory, and decision making) in severe obesity.
The purpose of this study is to determine differences between females' pain levels whether they are obese or non-obese, during different menstrual phases (premenstrual, postmenstrual and menopausal phases) through propofol injection pain given for induction of GA
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Study population Ninety patients, 18 years - 65yor older, physical status ASA I&II, scheduled to undergo elective gynecological surgery, will be enrolled in this prospective observational study.
- Patients' recruitment Patients will be recruited after admission to the hospital, same day they scheduled for surgery. All women who will meet inclusion criteria and gave written informed consent for participation in the study will be enrolled.
Patients will be divided into 2 groups according to BMI levels: Non obese (whether normal weight or overweight) = Group "NO" and obese = Group "O". Normal weight is defined as BMI 18.5-24.9, overweight as BMI 25.0-29.9 and obesity as BMI ≥ 30. [8] This study is a single blind study, where patients are aware of their menstrual status but supporting examiner is not aware of the patients' menstrual status.
Patients will be instructed on a vertical VAS 0-10 cm where (0) is marked as no pain and (10) is marked as the worst pain ever felt After standard anesthesia monitoring, Administration of oxygen will be performed for 3 minutes with 10 L/min fresh gas flow of 100% oxygen. After oxygen administration, 25% of (2 mg/kg) total propofol dose will be injected over 3-5 seconds (Propofol Lipuro 1%, B. Braun Melsungen AG, Germany). The patients will be observed and asked immediately whether they had pain in the arm, its VAS score, type of pain (burning, parathesia or other) and its onset will be documented (to differentiate early or late type of pain).
Another anesthesiologist, who is unaware of the study groups, will assess the intensity of pain after propofol injections.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Ain Shams University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years - 65yor older,
- physical status ASA I&II
Exclusion Criteria:
- irregular menstrual cycle,
- those who received hormonal therapy for any cause,
- on oral contraceptive pills,
- breast feeding,
- pregnant,
- history of total abdominal hysterectomy and/or bilateral salphingo-opherectomy.
- patients who had difficulty in understanding the visual analogue scale (VAS)/ pain scoring systems,
- renal or hepatic insufficiency,
- anticipated difficult tracheal intubation, and
- hypersensitivity to the study drugs.
- Also, patients on antidepressants and analgesics
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Non obese
Non obese (whether normal weight or overweight) = Group "NO"
|
After standard anesthesia monitoring, Administration of oxygen was performed for 3 minutes with 10 L/min fresh gas flow of 100% oxygen.
After oxygen administration, 25% of (2 mg/kg) total propofol dose was injected over 3-5 seconds (Propofol Lipuro 1%, B. Braun Melsungen AG, Germany).
The patients were observed and asked immediately whether they had pain in the arm, its VAS score, type of pain (burning, parathesia or other) and its onset was documented (to differentiate early or late type of pain).
Other Names:
|
Obese
obese = Group "O"
|
After standard anesthesia monitoring, Administration of oxygen was performed for 3 minutes with 10 L/min fresh gas flow of 100% oxygen.
After oxygen administration, 25% of (2 mg/kg) total propofol dose was injected over 3-5 seconds (Propofol Lipuro 1%, B. Braun Melsungen AG, Germany).
The patients were observed and asked immediately whether they had pain in the arm, its VAS score, type of pain (burning, parathesia or other) and its onset was documented (to differentiate early or late type of pain).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS score
Time Frame: immediately after injection
|
Incidence & severity of propofol injection pain (Mild pain was defined as VAS score 0-3, Moderate as VAS score 4-6, Severe as VAS score 7-10).
|
immediately after injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Type of Propofol injection pain, early or late (after 10 seconds)
Time Frame: after 10 seconds
|
Type of Propofol injection pain, early or late (after 10 seconds)
|
after 10 seconds
|
Hemodynamic variables
Time Frame: till 5 minutes after tracheal intubation
|
Hemodynamic variables were recorded before administration of the IV anesthetic, as well as after TI and 5 minutes later
|
till 5 minutes after tracheal intubation
|
Rate pressure products
Time Frame: till 5 minutes after tracheal intubation
|
Rate pressure products were calculated (an indicator of the heart's demand for oxygen) at same hemodynamic predetermined measuring timings.
|
till 5 minutes after tracheal intubation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Raham H Mostafa, MD, Ain Shams University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R43/2019 (Registry Identifier: Ain Shams research ethical committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Propofol Adverse Reaction
-
Hospital Central de la Defensa Gómez UllaCompleted
-
University of Texas Southwestern Medical CenterRecruitingAnesthesia | Anesthesia; Reaction | Anesthesia Complication | Anesthesia; Adverse Effect | Propofol Adverse Reaction | Etomidate Adverse ReactionUnited States
-
Brugmann University HospitalCompletedSedation Complication | Anesthesia; Adverse Effect | Propofol Adverse Reaction | Multiparametric Magnetic Resonance ImagingBelgium
-
Kyungpook National University HospitalRecruitingPain | Transcutaneous Electrical Nerve Stimulation | Propofol Adverse ReactionKorea, Republic of
-
Zhejiang Cancer HospitalCompletedHepatocellular Carcinoma | Circulating Tumor Cells | Desflurane Adverse Reaction | Propofol Adverse ReactionChina
-
RenJi HospitalThe First Affiliated Hospital of Nanchang University; Shanghai East Hospital; Affiliated Hospital of Jiaxing University and other collaboratorsRecruitingHypoxia | Gastric Cancer | Sedation Complication | Propofol Adverse ReactionChina
-
Galeno Desenvolvimento de Pesquisas ClínicasBiolab Sanus FarmaceuticaCompletedLidocaine Adverse Reaction | Prilocaine Adverse ReactionBrazil
-
The Leeds Teaching Hospitals NHS TrustLeeds Clinical Commissioning GroupRecruitingAdherence, Medication | Statin Adverse Reaction | Anticoagulant Adverse ReactionUnited Kingdom
-
Rigshospitalet, DenmarkUnknownAnalgesic Adverse Reaction | Gonad Regulating Hormone Adverse ReactionDenmark
-
Clinical Hospital Center ZemunWithdrawnBisoprolol Adverse Reaction | Nebivolol Adverse ReactionSerbia
Clinical Trials on Non obese
-
Kocaeli UniversityCompleted
-
Istanbul Medeniyet UniversityCompletedMetabolically Healthy ObesityTurkey
-
Yeditepe University HospitalCompletedObesity | Difficult Intubation
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); California...UnknownObesity | Weight Loss | Weight ControlUnited States
-
Wissenschaftliches Institut Bethanien e.VDeutsche Luft und RaumfahrtCompleted
-
Changhai HospitalShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University and other collaboratorsNot yet recruiting
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; Institut National de la Recherche Agronomique; Auvergne... and other collaboratorsUnknown
-
Charles University, Czech RepublicInstitut National de la Santé Et de la Recherche Médicale, France; Faculty...Completed
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Washington University School of MedicinePershing Square FoundationRecruitingObesity | Insulin ResistanceUnited States